Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
van Gelder, Michel
199  Ergebnisse:
Personensuche X
?
1

The GLOW trial in chronic lymphocytic leukaemia:

van Gelder, Michel ; Hoogendoorn, Mels ; te Raa, Doreen
The Lancet Oncology.  25 (2024)  2 - p. e55 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Benefits and risks of clofarabine in adult acute lymphoblas..:

Hermans, Sjoerd J. F. ; van Norden, Yvette ; Versluis, Jurjen...
Cancer Medicine.  13 (2024)  9 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
3

Autologous hematopoietic cell transplantation for T-cell pr..:

Drozd-Sokolowska, Joanna ; Gras, Luuk ; Koster, Linda...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
4

The European landscape on allogeneic haematopoeietic cell t..:

Tournilhac, Olivier ; van Gelder, Michel ; Eikema, Dirk-Jan...
Bone Marrow Transplantation.  58 (2023)  6 - p. 621-624 , 2023
Link: https://doi.org/10.1038/..
 
?
5

Clofarabine added to intensive treatment in adult patients ..:

Rijneveld, Anita W. ; van der Holt, Bronno ; de Weerdt, Okke...
Blood Advances.  6 (2022)  4 - p. 1115-1125 , 2022
Link: https://doi.org/10.1182/..
 
?
6

Posttransplant cyclophosphamide for prevention of graft-ver..:

Broers, Annoek E. C. ; de Jong, Cornelis N. ; Bakunina, Katerina...
Blood Advances.  6 (2022)  11 - p. 3378-3385 , 2022
Link: https://doi.org/10.1182/..
 
?
7

Allogeneic hematopoietic cell transplant for hairy cell leu..:

Chihara, Dai ; Gras, Luuk ; Zinger, Nienke...
Haematologica.  108 (2022)  6 - p. 1676-1679 , 2022
Link: https://doi.org/10.3324/..
 
?
8

Real‐world experience: Introduction of T cell replete haplo..:

van Gorkom, Gwendolyn ; Billen, Evy ; Van Elssen, Catharina..
eJHaem.  2 (2021)  3 - p. 440-448 , 2021
Link: https://doi.org/10.1002/..
 
?
9

Corrigendum: Haplotype Motif-Based Models for KIR-Genotype ..:

Schetelig, Johannes ; Baldauf, Henning ; Koster, Linda...
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
10

Correction to: Idelalisib treatment prior to allogeneic ste..:

Schetelig, Johannes ; Chevallier, Patrice ; van Gelder, Michel...
Bone Marrow Transplantation.  57 (2021)  2 - p. 330-330 , 2021
Link: https://doi.org/10.1038/..
 
?
11

ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA..:

Ehlers, Femke A. I. ; Beelen, Nicky A. ; van Gelder, Michel...
Cancers.  13 (2021)  13 - p. 3232 , 2021
Link: https://doi.org/10.3390/..
 
?
12

Correction to: Allogeneic hematopoietic cell transplantatio..:

Schetelig, Johannes ; Hoek, Jennifer ; Stilgenbauer, Stephan...
Bone Marrow Transplantation.  57 (2021)  1 - p. 144-144 , 2021
Link: https://doi.org/10.1038/..
 
?
13

Haplotype Motif-Based Models for KIR-Genotype Informed Sele..:

Schetelig, Johannes ; Baldauf, Henning ; Koster, Linda...
Frontiers in Immunology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
14

Alemtuzumab plus CHOP versus CHOP in elderly patients with ..:

for the ACT-2 study investigators ; Wulf, Gerald G. ; Altmann, Bettina...
Leukemia.  35 (2020)  1 - p. 143-155 , 2020
Link: https://doi.org/10.1038/..
 
?
15

Proteomic markers with prognostic impact on outcome of chro..:

Saberi Hosnijeh, Fatemeh ; van der Straten, Lina ; Kater, Arnon P....
Experimental Hematology.  89 (2020)  - p. 55-60.e6 , 2020
Link: https://doi.org/10.1016/..
 
1-15